Zhuhai, China

Linyan Lv


Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Linyan Lv: Innovator in Sustained-Release Drug Delivery Systems

Introduction

Linyan Lv is a notable inventor based in Zhuhai, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of drug delivery systems. His innovative work focuses on enhancing the efficacy and safety of medications through advanced formulation techniques.

Latest Patents

Linyan Lv holds a patent for an "Aripiprazole sustained-release microsphere and preparation method therefor." This invention provides a novel microsphere formulation that comprises aripiprazole and polylactide-glycolide. The microsphere features a spherical reticular skeleton structure with reticular micropores distributed across its surface, allowing for the effective encapsulation of aripiprazole within these micropores. The average particle diameter of the microsphere is less than 20 μm, making it suitable for administration through a 5 gauge needle. The content of aripiprazole in the microsphere ranges from 65% to 80% of its total weight, ensuring a sustained release of the drug.

Career Highlights

Linyan Lv is associated with Zhuhai Livzon Microsphere Technology Co. Ltd., where he continues to advance his research and development efforts. His work has positioned him as a key player in the field of microsphere technology, contributing to the improvement of drug delivery systems.

Collaborations

Linyan has collaborated with several professionals in his field, including Bin Chen and Xia Yin. These collaborations have fostered a productive environment for innovation and have led to advancements in their shared research interests.

Conclusion

Linyan Lv's contributions to the field of sustained-release drug delivery systems exemplify the importance of innovation in pharmaceuticals. His patented work on aripiprazole microspheres showcases his commitment to improving medication efficacy and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…